Preoperative MRI improves surgical outcomes in robotic prostatectomy
1. Among prostate cancer patients treated with robot-assisted radical prostatectomy, the use of preoperative prostate magnetic resonance (MR) imaging significantly reduced the risk of...
Urinary HPV testing accurate for cervical HPV detection
1. Urinary HPV testing showed a high sensitivity and specificity for detecting cervical HPV, and an especially high specificity for strains 16 and 18....
ACP recommends non-pharmacologic treatment of urinary incontinence in women
1. According to a new practice guideline from the American College of Physicians, non-pharmacological therapies for urinary incontinence (UI) in women, such as pelvic...
Prostate cancer screening shows reduction in mortality after 13 year follow-up [ERSPC trial]
1. Prostate cancer screening showed a continued reduction in prostate cancer incidence and mortality after a longer follow-up of 13 years compared to previous...
Strict blood pressure control in kidney disease linked to worse outcomes
1. Among patients with chronic kidney disease, a goal systolic blood pressure between 120-139 mmHg was associated with a lower mortality rate than a...
Shorter surveillance follow-up for stage I seminoma may be sufficient
1. A large, retrospective, population-based study of stage I seminoma patients followed by active surveillance post-orchiectomy demonstrated that the majority of relapses occurred within...
Increased risk of aggressive prostate cancer following vasectomy
1. Vasectomy was associated with a small increased risk of aggressive prostate cancer on extended long-term follow-up.
Evidence Rating Level: 2 (Good)
Study Rundown: The association...
Novel aromatase inhibitor, ODM-201, may be safe and effective for prostate cancer
1. In a phase I trial, ODM-201 was well tolerated up to 1800mg per day in prostate cancer patients, without reaching the maximum tolerated...
Obesity linked with prostate cancer progression
1. In men with low-risk prostate cancer undergoing active surveillance, obesity (BMI>30) was significantly associated with pathologic and therapeutic progression after the first confirmatory...
Use of 5α-reductase inhibitors may not increase risk of high-grade prostate cancer
Image: PD
1. The use of 5α-reductase inhibitors (5ARIs) was not associated with increased risk of developing high-grade or lethal prostate cancer.
2. 5ARI use...
